In this talk, I will describe our group’s efforts to develop real, working therapeutics that would be effective against both current and future strains of COVID-like viruses. Among the many painful historical lessons that we have learned or re-learned as a result of the recent COVID pandemic, we have developed a new respect for the facility of viral evolution to repeatedly render existing therapeutics, both vaccines and antibodies, obsolete. Are we doomed to forever play a cat-and-mouse game with viruses, with future unpleasant surprises lurking in zoonotic reservoirs? Is there any way to parley our atomic-level understanding of the action of biomolecules to explore the space of molecular possibilities in order to conceive, design and develop a molecule that would be a “universal vaccine”? Or an antibody that could block infection for the next latent variant of SARS-CoV-2? We are a group of both physicists and microbiologists working on addressing these challenges. In this talk I’ll discuss our proposed solutions.
Can we design and build novel molecular therapeutics for the next viral epidemic?
Host: Sarah Rauscher